Zobrazeno 1 - 10
of 44
pro vyhledávání: '"George T. Stevenson"'
Autor:
George T. Stevenson
Publikováno v:
Haematologica, Vol 99, Iss 10 (2014)
Antibodies against surface molecules of human tumors are now frequently administered in combination with strong chemotherapy, increasing therapeutic efficacy but making the task of elucidating immunological events more difficult. Experiments on genet
Externí odkaz:
https://doaj.org/article/2663aa50a72741febe92f5cc22f3f78b
Autor:
George T. Stevenson
Publikováno v:
Leukemia Research. 29:239-246
Evidence suggests that amelioration of childhood immune thrombocytopenic purpura and some other autoimmune states by intravenous normal IgG is due to the following chain of events: (1) cross-linking of Fcγ-receptors on blood effector cells; (2) rele
Autor:
Weng S. Leong, Valerie A. Anderson, Andrew Worth, Andrew M. Smith, George T. Stevenson, Kwok S. Kan
Publikováno v:
The Journal of Immunology. 166:1320-1326
We describe a two-stage preparation of chemically engineered Ab constructs, employing as modules Fab′γ from mAb or rAb, and Fc from human normal IgG1. A multivalent, optionally multispecific F(ab′)n core is formed in stage one, and one or more F
Autor:
Mark S. Cragg, George T. Stevenson
Publikováno v:
Seminars in Cancer Biology. 9:139-147
Molecular mapping of the cell surface has probably proceeded further with the human lymphocyte than with any other mammalian cell, and the B lymphocyte yields a wide range of subtly varying neoplasms. These two bodies of knowledge are now readily cor
Publikováno v:
Blood. 119(16)
Follicular lymphoma (FL) is a B-cell tumor arising in germinal centers and retaining features of its normal B-cell counterpart. Lymphomagenesis appears stepwise from the t(14;18) translocation, through FL-like cells, to FL in situ, then to overt FL.
Autor:
George T. Stevenson
Publikováno v:
Leukemia Research. 18:395-399
Our discussion is summarized in Fig. 1. Cytotoxic drugs are shown with the classical sigmoid relationship of response to log dose, with a parallel increase in toxicity which suits the Phase I approach. With antibody it is doubtful that clinical tumou
Publikováno v:
Molecular immunology. 48(5)
This work aims to enhance killing of antibody-coated human tumor cells by altering the antibody's affinity for two effector-cell Fcγ-receptors (FcγR). Affinity for the activating FcγRIII is raised, affinity for the inhibitory FcγRIIB is reduced,
Autor:
John Greenman, Christopher J. Slade, George T. Stevenson, Suzanne Nikoletti, Nancy Hogg, Martin J. Glennie
Publikováno v:
Cancer Immunology Immunotherapy. 34:361-369
The three forms of Fc gamma receptor carried by monocytes (Fc gamma RI, II) and natural killer (NK) cells (Fc gamma RIII) are all capable of mediating cell lysis. Here we compare the use of F(ab'gamma)2 bispecific antibodies, specifically targetting
Autor:
Andrew J.T. George, K.A.F. Pulford, Martin J. Glennie, Alison L. Tutt, J. Greenman, George T. Stevenson
Publikováno v:
Molecular Immunology. 28:1243-1254
Fc gamma RII (CDw32) on monocytes is capable of triggering both phagocytosis and lysis of chick red blood cells (CRBC) coated with antibody of the appropriate isotype. In this report we describe the production and characterization of a mouse monoclon
Autor:
Terence J. Hamblin, Freda K. Stevenson, Christopher J. Slade, Rebecca Cusack, George T. Stevenson, Andrew J. Bell, M B Spellerberg
Publikováno v:
Blood. 77:1071-1079
Multiple myeloma is a disease in which conventional chemotherapy has only limited value, but which may be ideal for treatment with passive antibody against a suitable cell surface antigen on the neoplastic plasma cell. The CD38 antigen is known to be